Invesco Biotechnology & Genome ETF
Invesco Ltd. PBE ETF
| PBE Price | $71.1984 |
Market Cap | $271.94M |
| Annual Dividend Yield | 0.05% |
Annual Dividend | $0.03 |
| Yearly Management Fee | 0.58% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Biotechnology |
Last 24h Volume | $4.64K |
| Portfolio Management Company | Invesco Ltd. |
Discount/Premium to NAV | 0.07% |
| Inception Date | Jun 23, 2005 |
Market Cap Rank | 1333 |
| Monthly AUM Growth | 1.60% |
Holdings Region | North America |
| Management Style | Passive |
Leverage | Non-Leveraged |
Invesco Biotechnology & Genome ETF is an ETF issued by Invesco Ltd. on Jun 23 2005.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of PBE ETF according to its net asset value is premiumed at 0.07%.
While the total value of the fund shows $4.28M increase compared to the previous month, its price is traded daily at a increase of 0.04%.
The annual dividend yield of PBE ETF is 0.05%, whereas its main asset area is North America.
PBE ETF, whose 24-hour total volume is $4.64K, has experienced a $-166,910 cash outflow in the last month.
In addition, Invesco Biotechnology & Genome ETF's one-year net asset value total return is 21.07%.
PBE ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| 0.04% |
2.12% |
2.31% |
11.95% |
9.12% |
8.53% |
21.80% |
PBE ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| -0.49% |
10.94% |
8.07% |
21.07% |
-6.56% |
42.07% |
PBE ETF Comments
no comments yet